T-REX 2X INVERSE CRWV DAILY TARGET ETF

18.74

-1.2000-6.02%

Volume:621.34K

Turnover:11.92M

Market Cap:11.53M

PE:- -

High:19.91

Open:19.26

Low:18.56

Close:19.94

52wk High:67.55

52wk Low:15.51

Shares:615.00K

Float Shares:615.00K

Volume Ratio:1.48

T/O Rate:101.03%

Dividend:- -

Dividend Rate:- -

ROE:--

ROA:--

PB:--

PE(LYR):- -

Loading ...

Overview Company News Filings

XORTX Announces Pioneering Research on Genome-Wide Pathogenic Pathways in Gout and Provides a Corporate Update

GlobeNewswire

·

Jan 01

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/CORD/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"CORD","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"CORD\",,,,,undefined,":{"symbol":"CORD","market":"US","secType":"STK","nameCN":"T-REX 2X INVERSE CRWV DAILY TARGET ETF","latestPrice":18.74,"timestamp":1768579372487,"preClose":19.94,"halted":0,"volume":621343,"delay":0,"floatShares":615000,"shares":615000,"eps":0,"marketStatus":"Trading","change":-1.2,"latestTime":"01-16 11:02:55 EST","open":19.26,"high":19.9053,"low":18.5563,"amount":11922287.854019001,"amplitude":0.067653,"askPrice":18.77,"askSize":300,"bidPrice":18.71,"bidSize":300,"shortable":0,"etf":-2,"ttmEps":0,"tradingStatus":2,"nextMarketStatus":{"tag":"Post-Mkt","tradingStatus":3,"beginTime":1768597200000},"marketStatusCode":2,"adr":0,"exchange":"CBOE","adjPreClose":19.94,"sharesOutstanding":615000,"nav":22.88,"aum":14070149.06,"bidAskSpread":0,"preHourTrading":{"tag":"盘前","latestPrice":19.09,"preClose":19.94,"latestTime":"09:27 EST","volume":18953,"amount":363149.92310300004,"timestamp":1768573674959},"postHourTrading":{"tag":"盘后","latestPrice":19.79,"preClose":19.94,"latestTime":"19:55 EST","volume":80970,"amount":1641669.8977,"timestamp":1768524938921},"volumeRatio":1.482617,"impliedVol":1.4633,"impliedVolPercentile":0.5526},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"CORD\",,,,,undefined,":{"symbol":"CORD","floatShares":615000,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":1.482617,"shares":615000,"dividePrice":0,"high":19.9053,"amplitude":0.067653,"preClose":19.94,"low":18.5563,"week52Low":15.5061,"pbRate":"--","week52High":67.545,"institutionHeld":0,"latestPrice":18.74,"eps":0,"divideRate":0,"volume":621343,"delay":0,"ttmEps":0,"open":19.26,"prevYearClose":39.8,"prevWeekClose":30.4,"prevMonthClose":39.8,"prevQuarterClose":39.8,"fiveDayClose":30.4,"twentyDayClose":61.02,"sixtyDayClose":22.7},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/CORD\",params:#limit:5,,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"CORD\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"CORD\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"CORD\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2600702479","title":"XORTX Announces Pioneering Research on Genome-Wide Pathogenic Pathways in Gout and Provides a Corporate Update","url":"https://stock-news.laohu8.com/highlight/detail?id=2600702479","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2600702479?lang=en_us&edition=fundamental","pubTime":"2026-01-01 07:15","pubTimestamp":1767222900,"startTime":"0","endTime":"0","summary":"Clinical Data doubles known genetic factors associated with urate and GoutCALGARY, Alberta, Dec.  31, 2025  (GLOBE NEWSWIRE) -- XORTX Therapeutics Inc. (\"XORTX\" or the “Company”) (NASDAQ: XRTX | TSXV:","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/12/31/3211946/0/en/XORTX-Announces-Pioneering-Research-on-Genome-Wide-Pathogenic-Pathways-in-Gout-and-Provides-a-Corporate-Update.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","CORD","ARDS","XRTX","BK4007"],"gpt_icon":0}],"pageSize":20,"totalPage":1,"pageCount":1,"totalSize":1,"code":"91000000","status":"200"}]}}